DexCom (DXCM) Stock Overview

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM Stock Information

Symbol

DXCM

Address

6340 Sequence DriveSan Diego, CA 92121United States

Founded

Trading hours

9:30 AM - 4:00 PM ET

Website

https://www.dexcom.com

Country

🇺🇸 United States

Phone Number

858 200 0200

DexCom (DXCM) Price Chart

DexCom Overview: Key Details and Summary

Stock data	2023	Change
Price	$75.26	N/A
Market Cap	$29.05B	N/A
Shares Outstanding	386.00M	-0.87%
Employees	7.50K	N/A
Shareholder Equity	2.07B	-2.96%

Valuation	2023	Change
P/E Ratio	57.89	N/A
P/S Ratio	8.02	N/A
P/B Ratio	14.04	N/A
P/FCF	56.75	N/A
POE	0.00	N/A

Growth	2023	Change
ROIC	0.2364	N/A
WACC	0.0030	N/A
CAPEX	-236.60M	N/A
Return on Equity	0.2618	N/A

Earnings	2023	Change
Revenue	$3.62B	N/A
Earnings	$541.50M	N/A
Free Cash Flow	$511.90M	N/A
EPS	1.30	N/A
Earnings Yield	0.0173	N/A
Gross Margin	0.6319	N/A
Operating Margin	0.165	N/A
Net income margin	0.1495	N/A
FCF Margin	0.1413	N/A

Financial Strength	2023	Change
Total Assets	$6.26B	N/A
Total Debt	$2.59B	N/A
Cash on Hand	$2.72B	N/A
Debt to Equity	$2.03	32.64%
Cash to Debt	$1.05	-8.29%
POE	0.0000	N/A
Current Ratio	$2.84	42.60%

Other data	2023	Change
Buyback Yield	0.0237	N/A